InfectiousDiseases COVID-19 Vaccine Clinic Appointments

COVID-19 Vaccine Clinic Appointments

Please be advised that the Province of Ontario recommends waiting 5 months (140 days) after your third dose of the COVID-19 vaccine before getting your fourth dose, as this will provide you with increased and longer-lasting protection. However, eligible clients may choose to get their fourth dose at a minimum interval of 3 months (84 days). If you wish to do so and you meet the current eligibility requirements for fourth dose, you can proceed to book a fourth dose of COVID-19 vaccine outside of the recommended interval and at a minimum interval of 3 months (84 days) after your third dose.

As part of a health care setting, masks will continue to be required while attending our COVID-19 vaccine clinics.

Please note: As of May 5, 2022, the Lynden Park Mall vaccine clinic will be relocated and will be next to Tip Top Tailors, accessible through the same entrance (Entrance #4).

Please review the following documents and the risk categories below before starting to book your appointment:

Who is eligible to receive a fourth dose vaccine?

As outlined by the Province, the following groups are eligible to receive a fourth dose COVID-19 vaccine:

Individuals 60 years-of-age or older:Individuals must be at least 60 years-of-age on the appointment date to receive a booster vaccine.

A fourth dose will be administered at a recommended interval of 5 months (140 days) or a minimum interval of 3 months (84 days)* after their third dose

First Nation, Inuit and Métis individuals aged 18 and over or a non-Indigenous household member aged 18 and over:

Adults must be at least 18 years-of-age on the appointment date to receive a booster vaccine.

A fourth dose will be administered at a recommended interval of 5 months (140 days) or a minimum interval of 3 months (84 days)* after their third dose

*Please be advised that the Province of Ontario recommends waiting 5 months (140 days) after your third dose of the COVID-19 vaccine before getting your fourth dose, as this will provide you with increased and longer-lasting protection. However, eligible clients may choose to get their fourth dose at a minimum interval of 3 months (84 days). If you wish to do so and you meet the current eligibility requirements for fourth dose, you can proceed to book a fourth dose of COVID-19 vaccine outside of the recommended interval and at a minimum interval of 3 months (84 days) after your third dose.

Individuals with high-risk health conditions
Moderate to severe immune compromised individuals who are 18+ are eligible for a fourth dose/booster three months (84 days) after completing their three dose primary series. This includes:

Individuals receiving active treatment (e.g., chemotherapy, targeted therapies, immunotherapy) for solid tumor or hematologic malignancies. Active treatment includes patients who have completed treatment within three months.
Recipients of solid-organ transplant and taking immunosuppressive therapy.
Recipients of chimeric antigen receptor (CAR)-T-cell therapy or hematopoietic stem cell transplant (within two years of transplantation or taking immunosuppression therapy).
Individuals with moderate to severe primary immunodeficiency (e.g., DiGeorge syndrome, Wiskott-Aldrich syndrome).
Individuals with Stage 3 or advanced untreated HIV infection and those with acquired immunodeficiency syndrome.
Individuals receiving dialysis (hemodialysis or peritoneal dialysis)
Individuals receiving active treatment with the following categories of immunosuppressive therapies: anti-B cell therapies (monoclonal antibodies targeting CD19, CD20 and CD22), high-dose systemic corticosteroids (refer to the CIG for suggested definition of high dose steroids), alkylating agents, antimetabolites, or tumor-necrosis factor (TNF) inhibitors and other biologic agents that are significantly immunosuppressive. Active treatment for patients receiving B-cell depleting therapy includes patients who have completed treatment within 12 months.

Suitable written documentation is required as eligibility will be checked at the time of the appointment. Those who do not meet the eligibility criteria will not receive the vaccine.

Residents of Long-Term Care Homes (LTCH), Retirement Homes (RH), Elder Care Lodges, and elderly living in other congregate settings (e.g. assisted-living facilities, chronic care hospitals)

Fourth doses may be scheduled a minimum of three months (84 days) after the previous dose.
Residents will receive vaccinations on-site at their applicable facility and do not need to book an appointment.

Receiving a COVID-19 vaccine after COVID-19 infection

NACI released recommendations surrounding the optimal interval for booster doses in vaccinated individuals who have recently become infected with COVID-19.

Individuals 5 years-of-age and older, infected with COVID-19 prior to their completion -or initiation of primary vaccine series are recommended to receive the next dose of vaccine 8 weeks after symptom onset or positive test.
Individuals 18 years of age and older, infected with COVID-19 after their primary series but before their booster dose, are recommended to receive their booster dose 3 months after symptom onset or positive test.

Individuals 12-17 year-of-age, infected with COVID-19 after their primary series but before their booster dose, are recommended to receive their booster dose 3 months after symptom onset or positive test, provided it's been at least 6 months after completing the primary series.

Individuals 5+ years-of-age who are not considered moderately to severely immunocompromised and with no previous history of multisystem inflammatory syndrome (MIS-C) in children can receive their first or second vaccine 8 weeks after symptom onset or positive test.

Individuals 5+ years-of-age who are moderately to severely immunocompromised and with no previous history of MIS-C can receive their first or second vaccine dose 4 to 8 weeks after symptoms onset or positive test.

Individuals 5+ years-of-age with a previous history of MIS-C (regardless of immunocompromised status) can receive their first or second vaccine dose when clinical recovery has been achieved or greater than 90 days since the onset of MIS-C, whichever is longer.

The recommended waiting times between the COVID-19 infection and vaccination are intended to minimize the risk of transmission of COVID-19 at an immunization clinic, enable monitoring for COVID-19 vaccine adverse events and increase immune response to vaccine. However, with informed consent individuals may opt to receive their first, second or a booster dose after symptoms of COVID-19 have resolved and they are no longer infectious.

Who is eligible to receive a third dose vaccine?

Individuals 18 years-of-age or older can get their third dose 3 months (84 days) after their second dose.

Individuals 12 to 17 years-of-age can get their third dose 6 months (168 days) after their second dose.

Please click here to review the following risk categories prior to booking your appointment

If any of the following risk categories apply to you, please take the respective action before booking and coming to your appointment:

Pregnant individuals – All pregnant individuals in the authorized age group are eligible and recommended to be vaccinated as soon as possible, at any stage in pregnancy, as COVID-19 infection during pregnancy can be severe, and the benefits of vaccination outweigh the risks. These individuals are encouraged to review any concerns with their treating health care provider and/or utilize the Vaccination in Pregnancy & Breastfeeding decision making tool on the MOH website Ministry of Health website.
Breastfeeding individuals – COVID-19 vaccines can be safely given to breastfeeding individuals and recent data shows that mRNA from vaccines do not transfer into breast milk. Anti-COVID-19 antibodies produced by the breastfeeding person have been shown to transfer through the milk and provide protection to the infant.
Autoimmune condition/immunocompromised due to disease or treatment that are receiving stem cell therapy, CAR-T therapy, chemo, immune checkpoint inhibitors, monoclonal antibodies, and other targeted agents are strongly encourage you to consult with your treating provider regarding timing of vaccination in relation to therapy and/or treatment modification to ensure the impact of the immunosuppressive therapy on vaccine effectiveness is as minimal as possible.
All other individuals with autoimmune/immunocompromised due to disease and immunocompromised due to treatment – may choose to consult with their treating provider but not required prior to vaccination.
Severe allergic reaction or anaphylaxis to a previous dose of a COVID-19 vaccine or to any of its components should not receive the COVID-19 vaccine in a general vaccine clinic. An urgent referral to an allergist/immunologist is recommended to assess the method for possible (re)administration of a COVID-19 vaccine.
Immediate allergic reaction to a previous dose of a COVID-19 vaccine or to any of its components –requires evaluation by an allergist/immunologist and documentation of allergist to determine if the vaccine can be safely administered. Documentation of the discussion with the allergist/immunologist must be provided to the clinic and include a vaccination care plan (including what types of parameters the clinic should meet to provide safe vaccination administration, e.g., availability of advanced medical care), details/severity of the previous allergic episode(s), confirm that appropriate counselling on the safe administration of vaccine was provided, and include the date, the clinician’s name, signature and contact information as well as the individual’s name and date of birth.
Severe/immediate allergic reaction to other vaccines or injectable therapies – does not require consultation with an allergist prior to vaccination but client will be asked to wait 30 minutes post vaccination for observation.
Significant or anaphylactic allergic reactions to other allergens does not require consultation with an allergist prior to vaccination. Client will be asked to wait the typical 15-minute observation time.

Reports

COVID-19 Vaccine Clinic Appointments

Who is eligible to receive a fourth dose vaccine?

Receiving a COVID-19 vaccine after COVID-19 infection

Who is eligible to receive a third dose vaccine?

Please click here to review the following risk categories prior to booking your appointment

COVID-19 Vaccine Booking Form